about
Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infectionIntegration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesisImpact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort StudyMethods to study tumor surveillance using tumor cell transplantation into genetically engineered mice.Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillanceAntagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts.Type I Interferon Signaling Prevents IL-1β-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft Tissue.Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells.Type I interferons have opposing effects during the emergence and recovery phases of colitis.Natural killer cell-intrinsic type I IFN signaling controls Klebsiella pneumoniae growth during lung infection.A mouse model to identify cooperating signaling pathways in cancerCommentary on H. Ide et al., “Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells”Afatinib restrains K-RAS–driven lung tumorigenesisSTAT3β is a tumor suppressor in acute myeloid leukemiaA Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions
P50
Q27345078-C331F863-620B-479C-BE00-F18AB29806DDQ33967257-E9C66AB6-66CD-4068-9FFF-1B5519D8CC24Q35196919-28E0E533-3B5B-449C-BDF7-8426513E1B91Q37624237-3C8C3D09-1544-4074-A7BE-7EA5F92413B3Q38914880-C5A1F942-36DA-41E6-A5DC-9779916CC0F9Q39241252-737F10BD-03F6-4597-8D15-9F3B55E78F1FQ39439263-2AA776B3-F36D-43F9-9656-76BA05CB7E15Q39441263-655A0768-A15F-4073-A7A1-7EAD930AA45AQ40760672-665FDBC7-4C18-458A-9D39-E1946A21EA41Q42594064-E66426CA-7891-42FC-A5CE-F7B5F83E5E40Q42821539-9B08B498-9119-4F1B-96DE-4FE6A0F6D14AQ44257300-D42FC5D6-46D7-468E-B330-5B3FB984F0F3Q47156883-FC31A390-C031-4A0C-BF79-009332FDB5BDQ57174124-CD28E50D-C2F8-4EB5-A22B-A96DC151A4D1Q57174152-28F8170F-2504-468D-AF3C-58CD10D34F21Q61714947-6331C8FF-BBEF-4D0C-B040-78C043FD42EFQ91591549-54883BD6-5FE2-4478-9A12-EF1EF165F1F4Q92826134-357A31B8-3CEE-435B-B6C9-56823030659C
P50
description
researcher
@en
wetenschapper
@nl
name
Dagmar Stoiber
@en
Dagmar Stoiber
@nl
type
label
Dagmar Stoiber
@en
Dagmar Stoiber
@nl
prefLabel
Dagmar Stoiber
@en
Dagmar Stoiber
@nl
P106
P31
P496
0000-0002-8824-0767